BGIM
HRTX icon

Brandywine Global Investment Management’s Heron Therapeutics HRTX Stock Holding History

Brandywine Global Investment Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,815
Closed -$139K – 788
2020
Q1 		$139K Sell
11,815
-37
-0.3% -$696 ﹤0.01% 612
2019
Q4 		$275K Sell
11,852
-15
-0.1% -$332 ﹤0.01% 614
2019
Q3 		$220K Sell
11,867
-10,578
-47% -$195K ﹤0.01% 622
2019
Q2 		$418K Buy
22,445
+957
+4% +$19.1K ﹤0.01% 598
2019
Q1 		$526K Sell
21,488
-5,005
-19% -$131K ﹤0.01% 569
2018
Q4 		$688K Sell
26,493
-715
-3% -$19.7K 0.01% 555
2018
Q3 		$862K Buy
27,208
+28
+0.1% +$1.04K 0.01% 574
2018
Q2 		$1.06M Sell
27,180
-21,097
-44% -$672K 0.01% 581
2018
Q1 		$1.33M Sell
48,277
-21,508
-31% -$488K 0.01% 570
2017
Q4 		$1.26M Sell
69,785
-8,448
-11% -$138K 0.01% 572
2017
Q3 		$1.26M Sell
78,233
-2,637
-3% -$41.4K 0.01% 577
2017
Q2 		$1.12M Sell
80,870
-11,010
-12% -$159K 0.01% 600
2017
Q1 		$1.38M Buy
91,880
+51,429
+127% +$712K 0.01% 584
2016
Q4 		$530K Sell
40,451
-18,662
-32% -$293K ﹤0.01% 619
2016
Q3 		$1.02M Sell
59,113
-353
-0.6% -$6.55K 0.01% 587
2016
Q2 		$1.07M Sell
59,466
-14,619
-20% -$285K 0.01% 586
2016
Q1 		$1.41M Sell
74,085
-6,865
-8% -$135K 0.01% 560
2015
Q4 		$2.16M Buy
+80,950
New +$2.16M 0.01% 548

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brandywine Global Investment Management's HRTX Position: Q2 2020 in Review

Brandywine Global Investment Management sold out of Heron Therapeutics (HRTX) in Q2 2020, closing a stake of 11,815 shares — an estimated $139K sold.

Brandywine Global Investment Management first reported a position in HRTX in Q4 2015 and held it in 18 quarters. The position peaked at $2.16M in Q4 2015. 190 funds tracked by Wall St. Rank hold HRTX as of Q2 2020.

  • Brandywine Global Investment Management reported no remaining Heron Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Brandywine Global Investment Management sold 11,815 Heron Therapeutics shares in Q2 2020, an estimated $139K.
  • Brandywine Global Investment Management first reported a position in Heron Therapeutics in Q4 2015 and held it in 18 quarters.
  • Brandywine Global Investment Management's Heron Therapeutics position peaked at $2.16M in Q4 2015.
  • 190 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2020.

Based on Brandywine Global Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.